Westwood Holdings Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Sell |
30,514
-8,552
| -22% | -$416K | 0.01% | 329 |
|
|
2025
Q1 | $1.33M | Sell |
39,066
-14,036
| -26% | -$478K | 0.01% | 346 |
|
|
2024
Q4 | $2.09M | Buy |
53,102
+8,120
| +18% | +$320K | 0.02% | 317 |
|
|
2024
Q3 | $2.11M | Buy |
44,982
+7,607
| +20% | +$357K | 0.01% | 329 |
|
|
2024
Q2 | $2.02M | Buy |
37,375
+22,516
| +152% | +$1.22M | 0.01% | 315 |
|
|
2024
Q1 | $1.01M | Sell |
14,859
-30,473
| -67% | -$2.08M | 0.01% | 358 |
|
|
2023
Q4 | $2.84M | Sell |
45,332
-129,856
| -74% | -$8.13M | 0.02% | 282 |
|
|
2023
Q3 | $7.95M | Buy |
175,188
+85,158
| +95% | +$3.87M | 0.07% | 204 |
|
|
2023
Q2 | $5.05M | Sell |
90,030
-3,509
| -4% | -$197K | 0.05% | 249 |
|
|
2023
Q1 | $4.23M | Buy |
93,539
+63,360
| +210% | +$2.87M | 0.04% | 260 |
|
|
2022
Q4 | $1.23M | Sell |
30,179
-2,150
| -7% | -$87.4K | 0.01% | 336 |
|
|
2022
Q3 | $2.11M | Sell |
32,329
-9,945
| -24% | -$650K | 0.03% | 260 |
|
|
2022
Q2 | $2.57M | Buy |
42,274
+23,582
| +126% | +$1.43M | 0.03% | 269 |
|
|
2022
Q1 | $1.17M | Buy |
18,692
+9,439
| +102% | +$593K | 0.01% | 345 |
|
|
2021
Q4 | $701K | Sell |
9,253
-10,040
| -52% | -$761K | 0.01% | 366 |
|
|
2021
Q3 | $2.16M | Buy |
19,293
+9,310
| +93% | +$1.04M | 0.02% | 280 |
|
|
2021
Q2 | $1.62M | Buy |
+9,983
| New | +$1.62M | 0.02% | 307 |
|